Testing Experimental Medication in Healthy Subjects

A Single Ascending Dose Trial of CVL-936 in Healthy Subjects

The aim of this trial is to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CVL-936 following single ascending oral doses in healthy subjects.

Pharmaceutical medication involved
Patients and healthy individuals accepted

Drug - CVL-936


Drug - Matching Placebo

Placebo matching CVL-936

A Phase 1, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In-Human Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Ascending Doses of CVL-936 In Healthy Subjects